The Potential Effectiveness of an Ancient Chinese Herbal Formula Yupingfengsan for the Prevention of COVID-19: A Systematic Review

Abstract

The COVID-19 has been spreading all over the world, and human health is at stake. Conventional medicine played an important role in the treatment and syndrome relief, while there is limited research evidence to support any prevention or antiviral treatment for COVID-19. Yupingfengsan is a classic formula with the effect of replenishing qi, consolidating exterior, and arresting sweating. Yupingfengsan has been widely used to treat various diseases in China and Southeast Asia for hundreds of years. Accumulating evidence suggests that YPFS has both immune-regulatory and anti-virus effects clinically, but leaving the mechanism elusive. In this paper, we reviewed the recent progress of Yupingfengsan in immune-regulatory and anti-virus activities, including the effect on mucosal immunity, biological antagonism, macrophages, adaptive immunity, and natural killer cells. From this systematic review, we speculate that YPFS can play an effective role in the prevention of SARS-CoV-2, but further experimental studies are expected to investigate the specific mechanisms. This review suggests an alternative direction for the prevention of COVID-19.

Keywords

Yupingfengsan / Traditional Chinese Medicine / COVID-19 / immune-regulatory / review

References

[1] Shi, Y., Wang, G., Cai, X. P., Deng, J. W., Zheng, L., Zhu, H. H., ..., & Chen, Z. (2020). An overview of COVID—19. Journal of Zhejiang University Science B, 21(5), 343-360. https://doi.org/10.1631/jzus.B2000083

[2] Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., ..., & Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5

[3] Bulut, C., & Kato, Y. (2020). Epidemiology of COVID—19. Turkish Journal of Medical Sciences, 50(9), 563-570. https://doi.org/10.3906/sag-2004-172

[4] , Ni, L., Chen, L., Huang, X., Han, C., Xu, J., Zhang, H., ..., & Chen, H. (2020). Combating COVID—19 with integrated traditional Chinese and Western medicine in China. Acta Pharmaceutica Sinica B, 10(7), 1149-1162. https://doi.org/10.1016/j.apsb.2020.06.009

[5] Lau, T. F., Leung, P. C., Wong, E. L. Y., Fong, C., Cheng, K. F., Zhang, S. C., ..., & Ko, W. M. (2005). Using herbal medicine as a means of prevention experience during the SARS crisis. The American Journal of Chinese Medicine, 33(3), 345-356. https://doi.org/10.1142/S0192415X05002965

[6] Luo, H., Tang, Q. L., Shang, Y. X., Liang, S. B., Yang, M., Robinson, N., & Liu, J. P. (2020). Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID—19)? A review of historical classics, research evidence and current prevention programs. Chinese Journal of Integrative Medicine, 26(4), 243-250. https://doi.org/10.1007/s11655-020-3192-6

[7] Wang, Y., Wang, Y., Ma, J., Li, Y., Cao, L., Zhu, T., ..., & Liu, H. (2023). Yupingfengsan ameliorates LPS—induced acute lung injury and gut barrier dysfunction in mice. Journal of Ethnopharmacology, 312, 116452. https://doi.org/10.1016/j.jep.2023.116452

[8] Wang, X. T., Liu, H. L., Yu, X., Wang, C., Gui, L. L., Wang, X. Y., ..., & Hong, M. (2019). Chinese medicine Yu—Ping—Feng—San attenuates allergic inflammation by regulating epithelial derived pro—allergic cytokines. Chinese Journal of Natural Medicines, 17(7), 525-534. https://doi.org/10.1016/S1875-5364(19)30074-3

[9] Wang, R., Wang, J., Shu, J., Gu, X., Li, H., Zi, Y., ..., & Lin, J. (2020). Efficacy and safety of Yu—Ping—Feng powder for asthma in children: A protocol of systematic review and meta—analysis of randomized controlled trials. Medicine, 99(1), e18551. https://doi.org/10.1097/MD.0000000000018551

[10] Ma, K., Liu, Y., Kang, S., Zhang, N., & Shi, X. (2020). yù píng fēng sàn zhì jì de yào xué shí yàn jí lín chuáng yìng yòng jìn zhǎn yán jiū [Research on the progress of pharmaceutical experiment and clinical application of Yupingfeng powder preparation]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 29(5), 565-570.

[11] Al—Romaima, A., Liao, Y., Feng, J., Qin, X., & Qin, G. (2020). Advances in the treatment of novel coronavirus disease (COVID—19) with Western medicine and traditional Chinese medicine: A narrative review. Journal of Thoracic Disease, 12(10), 6054-6069. https://doi.org/10.21037/jtd-20-1810

[12] Yin, L., Gao, Y., Li, Z., Wang, M., & Chen, K. (2021). Analysis of Chinese herbal formulae recommended for COVID—19 in different schemes in China: A data mining approach. Combinatorial Chemistry & High Throughput Screening, 24(7), 957-967. https://doi.org/10.2174/1386207323666201001114101

[13] Xu, B., Li, X., Hu, S., Bao, Y., Chen, F., Chen, Z., ..., & Shen, K. (2022). Safety and efficacy of Yupingfeng granules in children with recurrent respiratory tract infection: A randomized clinical trial. Pediatric Investigation, 6(2), 75-84. https://doi.org/10.1002/ped4.12326

[14] Fang, S. (2010). yù pínɡ fēnɡ sàn zhì liáo fǎn fù hū xī dào ɡǎn rǎn lín chuánɡ liáo xiào jí duì jī tǐ miǎn yì ɡōnɡ nénɡ de yǐnɡ xiǎnɡ [The clinical effect of Yupingfeng powder in the treatment of repeated respiratory infections and its influence on the immune function of the body]. Chinese Archives of Traditional Chinese Medicine, 28(10), 2239-2240.

[15] Liu, Y. X., Zhou, Y. H., Jiang, C. H., Liu, J., & Chen, D. Q. (2022). Prevention, treatment and potential mechanism of herbal medicine for Corona viruses: A review. Bioengineered, 13(3), 5480-5508. https://doi.org/10.1080/21655979.2022.2036521

[16] Liu, Q., Lu, L., Hua, M., Xu, Y., Xiong, H., Hou, W., & Yang, Z. (2013). Jiawei—Yupingfeng—Tang, a Chinese herbal formula, inhibits respiratory viral infections in vitro and in vivo. Journal of Ethnopharmacology, 150(2), 521-528. https://doi.org/10.1016/j.jep.2013.08.056

[17] Liang, Y., Wang, M. L., Chien, C. S., Yarmishyn, A. A., Yang, Y. P., Lai, W. Y., ..., & Chiou, S. H. (2020). Highlight of immune pathogenic response and hematopathologic effect in SARS—CoV, MERS—CoV, and SARS—Cov—2 infection. Frontiers in Immunology, 11, 1022. https://doi.org/10.3389/fimmu.2020.01022

[18] Sinha, D., Yaugel—Novoa, M., Waeckel, L., Paul, S., & Longet, S. (2024). Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses. Antiviral Research, 223, 105823. https://doi.org/10.1016/j.antiviral.2024.105823

[19] Miyamoto, S., Nishiyama, T., Ueno, A., Park, H., Kanno, T., Nakamura, N., ..., & Suzuki, T. (2023). Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS—CoV—2 infection. Proceedings of the National Academy of Sciences, 120(52), e2314808120. https://doi.org/10.1073/pnas.2314808120

[20] Paces, J., Strizova, Z., Smrz, D., & Cerny, J. (2020). COVID—19 and the immune system. Physiological Research, 69(3), 379-388. https://doi.org/10.33549/physiolres.934492

[21] Zhang, L., Li, D., & Wu, X. (2007). yù pínɡ fēnɡ sàn zǒnɡ duō tánɡ yǐnɡ xiǎnɡ chánɡ dào nián m´o sǔn shānɡ xiǎo shǔ chánɡ—hū xī dào IgA fēn mì yán jiū [Study on the effect of total polysaccharides of Yupingfeng powder on intestinal—respiratory tract IgA secretion in mice with intestinal mucosal injury]. Pharmacology and Clinics of Chinese Materia Medica, 23(5), 43-45.

[22] Xu, P., Ding, W., Zhao, F., Xiang, Y., Li, X., & Zhang, F. (2012). zhōnɡ yào yù fánɡ liú ɡǎn zuò yònɡ yǔ nián m´o miǎn yì xiānɡ ɡuān xìnɡ yán jiū [Research the relations between the efficacy of Chinese medicine in the prevention influenza and mucosal immune]. Chinese Journal of Immunology, 28, 992-998.

[23] Bernheim, A., & Sorek, R. (2020). The pan—immune system of bacteria: Antiviral defence as a community resource. Nature Reviews Microbiology, 18(2), 113-119. https://doi.org/10.1038/s41579-019-0278-2

[24] Hao, S., Fan, Q., Bai, Y., Fang, H., Zhou, J., Fukuda, T., ..., & Li, W. (2020). Core fucosylation of intestinal epithelial cells protects against salmonella typhi infection via up—regulating the biological antagonism of intestinal microbiota. Frontiers in Microbiology, 11, 1097. https://doi.org/10.3389/fmicb.2020.01097

[25] Xu, Y., Yuan, J., Chen, W., Xing, H., Guo, J., & Yang, Z. (2010). yù pínɡ fēnɡ sàn zhōnɡ jūn chén liǎnɡ yào fú zhí shànɡ hū xī dào yōu shì jūn jiǎ xínɡ liàn qiú jūn de yán jiū [Research to fostering the role of that Junchen two Chinese medicines in the Yupingfen San on the advantage of the upper respiratory tract bacteria alpha—Streptococcus]. Acta Chinese Medicine and Pharmacology, 38(2), 16-18.

[26] Peng, J., Chen, J., Tian, S., Xing, H., & Yuan, J. (2016). yù pínɡ fēnɡ sàn jiā wèi fānɡ duì màn xìnɡ zǔ sè xìnɡ fèi jí bìnɡ dà shǔ qì dào 3 zhǒnɡ xì jūn de yǐnɡ xiǎnɡ [Effect of modified Yupingfeng San on three kinds of bacteria in airway of COPD Rats]. Chinese Journal of Experimental Traditional Medical Formulae, 22(18), 123-126.

[27] Tang, L., Shang, Y., Lu, S., Huang, J., & Yuan, J. (2012). yù pínɡ fēnɡ sàn duì miǎn yì yì zhì xiǎo shǔ kǒu yàn bù jiǎ xínɡ liàn qiú jūn de tiáo jié zuò yònɡ [Regulating effects of Yupingfeng powder on α—Hemolytic streptococcus in oropharyngeal ecosystem of immunosuppression mice]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 21(18), 1995-1957.

[28] Guan, Y., Zheng, W., Bai, Y., & Wu, B. (2024). Yupingfeng polysaccharide promote the growth of chickens via regulating gut microbiota. Frontiers in Veterinary Science, 11, 1337698. https://doi.org/10.3389/fvets.2024.1337698

[29] Merad, M., & Martin, J. C. (2020). Pathological inflammation in patients with COVID-19: A key role for monocytes and macrophages. Nature Reviews Immunology, 20(6), 355-362. https://doi.org/10.1038/s41577-020-0331-4

[30] Sun, H., Ni, X., Zeng, D., Zou, F., Yang, M., Peng, Z., ..., & Jing, B. O. (2017). Bidirectional immunomodulating activity of fermented polysaccharides from Yupingfeng. Research in Veterinary Science, 110, 22-28. https://doi.org/10.1016/j.rvsc.2016.10.015

[31] Zhang, H., Tang, X., Ju, B., & Song, B. (2008). yù pínɡ fēnɡ sàn duì S180 hé liú xiǎo shǔ zhǒnɡ liú shēnɡ zhǎnɡ jí miǎn yì ɡōnɡ nénɡ de yǐnɡ xiǎnɡ [The effect of Yupingfeng powder on tumor growth and immune function of S180 tumor-bearing mice]. Chinese Journal of Cellular and Molecular Immunology, 24(7), 683-685.

[32] Li, X. (2005). yù pínɡ fēnɡ sàn pèi wǔ duì xiǎo shǔ miǎn yì ɡōnɡ nénɡ de yǐnɡ xiǎnɡ [Effects of Yupingfeng powder on the immune function of mice]. Master’s Thesis, Heilongjiang University of Chinese Medicine.

[33] Gan, L. (2013). yù pínɡ fēnɡ sàn duō tánɡ duì xiǎo shǔ miǎn yì ɡōnɡ nénɡ de yǐnɡ xiǎnɡ [Effect of Yupingfengsan polysaccharide on immune function of mice]. Immunological Journal, 29(2), 182-184.

[34] Zeng, G., Chen, X., Liu, J., Zhong, X., Dai, L., Zhao, L., & Shen, G. (2005). jiā wèi yù pínɡ fēnɡ sàn duì chuānɡ shānɡ yīnɡ jī xiǎo shǔ xì bāo miǎn yì ɡōnɡ nénɡ de yǐnɡ xiǎnɡ [Effect of modified Yupingfeng powder on cellular immune function in mice of wound stress]. Journal of Traditional Chinese Medicine, 46(5), 380-382.

[35] Li, Y., Zheng, B., Tian, H., Xu, X., Sun, Y., Mei, Q., ..., & Liu, L. (2017). Yupingfeng powder relieves the immune suppression induced by dexamethasone in mice. Journal of Ethnopharmacology, 200, 117-123. https://doi.org/10.1016/j.jep.2017.01.054

[36] Fan, W., Zheng, P., Wang, Y., Hao, P., Liu, J., & Zhao, X. (2017). Analysis of immunostimulatory activity of polysaccharide extracted from Yu-Ping-Feng in vitro and in vivo. Biomedicine & Pharmacotherapy, 93, 146-155. https://doi.org/10.1016/j.biopha.2017.05.138

[37] Yao, F., Yuan, Q., Song, X., Zhou, L., Liang, G., Jiang, G., & Zhang, L. (2020). Yupingfeng granule improves Th2-biased immune state in microenvironment of hepatocellular carcinoma through TSLP-DC-OX40L pathway. Evidence-Based Complementary and Alternative Medicine, 2020(1), 1263053. https://doi.org/10.1155/2020/1263053

[38] Chen, L., & Xu, J. (2006). yù pínɡ fēnɡ sàn zhì liáo dān chún xìnɡ shèn bìnɡ zōnɡ hé zhēnɡ ér t´onɡ jì fā xìnɡ miǎn yì ɡōnɡ nénɡ dī xià [Effects of Yupingfeng powder on secondary immunodeficiency caused by simple nephrotic syndrome in children]. Chinese Journal of Applied Clinical Pediatrics, 21(23), 1662-1663.

[39] Zhu, X., Li, K., Chen, X., Zhang, Y., Han, J., Lu, X., ..., & Zhang, W. (2018). yù pínɡ fēnɡ sàn duì méi yān xiānɡ ɡuān kě xī rù kē lì wù zhì fèi sǔn shānɡ m´o xínɡ xiǎo shǔ miǎn yì ɡōnɡ nénɡ de ɡān yù zuò yònɡ [Effect of Yupingfeng San on immune function of lung injury mice induced by smoked soot-related respirable particulate]. Chinese Journal of Experimental Traditional Medical Formulae, 24(8), 103-109.

[40] Bai, Y., Wei, W., Yao, C., Wu, S., Wang, W., & Guo, D. A. (2023). Advances in the chemical constituents, pharmacological properties and clinical applications of TCM formula Yupingfeng San. Fitoterapia, 164, 105385. https://doi.org/10.1016/j.fitote.2022.105385

[41] Qi, J. (2008). yù pínɡ fēnɡ sàn zhōnɡ bǔ yì yào hé jiě biǎo yào pèi wǔ duì xiǎo shǔ miǎn yì ɡōnɡ nénɡ de yǐnɡ xiǎnɡ shuò shì [Effects of compatibility of tonic and anti-blood drugs in Yupingfeng powder on immune function of mice]. Master’s Thesis, Changchun University of Chinese Medicine.

[42] Soleimanian, S., & Yaghobi, R. (2020). Harnessing memory NK cell to protect against COVID-19. Frontiers in Pharmacology, 11, 1309. https://doi.org/10.3389/fphar.2020.01309

[43] Market, M., Angka, L., Martel, A. B., Bastin, D., Olanubi, O., Tennakoon, G., ..., & Auer, R. C. (2020). Flattening the COVID-19 curve with natural killer cell based immunotherapies. Frontiers in Immunology, 11, 1512. https://doi.org/10.3389/fimmu.2020.01512

[44] Liang, C., Wang, X., Dong, Q., & Wu, M. (2003). yù pínɡ fēnɡ sàn duì xiǎo shǔ miǎn yì tiáo jié zuò yònɡ de xuè qīnɡ yào lǐ xué yán jiū [A serum pharmacological study on the immunoregulatory effects of Yu Ping Feng Pulvis in mice]. Shanghai Journal of Immunology, 23(6), 385-388.

[45] Chen, X., Yang, L., Zeng, G., & Shen, G. (2000). jiā wèi yù pínɡ fēnɡ tānɡ duì jié zhī yīnɡ jī xiǎo shǔ xì bāo miǎn yì ɡōnɡ nénɡ de tiáo jié zuò yònɡ [The regulatory action of the modified Yu Ping Feng Tang on cellular immunity in mice under amputation-induced stress]. Journal of Traditional Chinese Medicine, 20(4), 302-306.

[46] Chen, J., Chen, D., Yu, X., Li, L., Wu, F., Liang, H., & Huang, J. (2014). yù pínɡ fēnɡ yào yè duì huán lín xiān àn yì zhì de C57BL/6 xiǎo shǔ miǎn yì ɡōnɡ nénɡ de yǐnɡ xiǎnɡ [Effect of Yupingfeng solution on the immune function of C57BL/6 mice inhibited by Cyclophosphamide]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 23(23), 2509-2515.

[47] Li, R., Yu, C., Chen, X., Liu, P., Lu, B., & Zhao, X. (2011). yù pínɡ fēnɡ sàn yù fánɡ rén piān fèi bìnɡ dú ɡǎn rǎn de shí yàn yán jiū [Prophylaxis of Chinese ancient presciription Yupingfeng powder reduces histopathologic changes and viral replication in mouse lungs caused by human metapneumovirus]. China Journal of Traditional Chinese Medicine and Pharmacy, 26(10), 2288-2291.

[48] Xiang, Y. (2013). zhōnɡ yào ɡān yù shǔ liú ɡǎn de zuò yònɡ jí yǔ nián m´o miǎn yì xiānɡ ɡuān xìnɡ yán jiū [The function on Chinese medicine intervening the mouse infected by influenza and the correlation with mucosal immunity]. Master’s Thesis, Guangzhou University of Chinese Medicine.

[49] Lv, H., Han, X., & Wang, P. (2008). yù pínɡ fēnɡ sàn fánɡ zhì fù fā xìnɡ dān chún pào zhěn bìnɡ dú xìnɡ jiǎo m´o yán 36 lì lín chuánɡ ɡuān chá [Clinical observation on treatment of 36 cases of recurrent herpes simplex virus keratitis with Yupingfeng powder]. The Journal of Practical Medicine, 24(2), 308-309.

[50] Zhang, Z. (2004). yù pínɡ fēnɡ sàn lián hé xī yào zhì liáo lǎo nián dài zhuànɡ pào zhěn lín chuánɡ ɡuān chá [Clinical observation on treatment of Senile Herpes Zoster with Yupingfeng powder and western medicine]. Journal of Sichuan of Traditional Chinese Medicine, 22(9), 76-79.

[51] Jia, Y., Yu, Y., He, H., Cao, L., & Wang, Z. (2020). lì yònɡ fèn zǐ duì jiē jì shù shāi xuǎn pínɡ jià yù pínɡ fēnɡ sàn zhōnɡ hu´o xìnɡ huà hé wù duì SARS-CoV-2 ɡǎn rǎn fù zhì zēnɡ zhí ɡuò chénɡ zhōnɡ ɡuān jiàn bǎ diǎn de qián zài yì zhì hu´o xìnɡ [Potential inhibitory activity of active compounds in Yupingfeng San against key targets during the infection, replication and proliferation of SARS-CoV-2 based on molecular docking]. Pharmacology and Clinics of Chinese Materia Medica, 36(6), 24-30.

[52] Zhan, Q., Huang, Y., Lin, S., & Chu, Q. (2020). jī yú wǎnɡ luò yào lǐ xué hé fèn zǐ duì jiē de yù pínɡ fēnɡ sàn yù fánɡ xīn xínɡ ɡuàn zhuànɡ bìnɡ dú fèi yán (COVID-19) hu´o xìnɡ huà hé wù de yán jiū [Study on active compounds of Yupingfeng San for prevention of coronavirus disease 2019 (COVID-19) based on network pharmacology and molecular docking]. Chinese Traditional and Herbal Drugs, 51(7), 1731-1740.

[53] Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020). Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology, 94(7), e00127-20. https://doi.org/10.1128/jvi.00127-20

[54] Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., ..., & Wang, X. (2020). Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature, 581(7807), 215-220. https://doi.org/10.1038/s41586-020-2180-5

[55] Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C. L., Abiona, O., ..., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, 367(6483), 1260-1263. https://doi.org/10.1126/science.abb2507

[56] Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., ..., & Rao, Z. (2020). Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science, 368(6492), 779-782. https://doi.org/10.1126/science.abb7498

[57] Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., ..., & Yang, H. (2020). Structure of M^pro from SARS-CoV-2 and discovery of its inhibitors . Nature, 582(7811), 289-293. https://doi.org/10.1038/s41586-020-2223-y

[58] Gold, I. M., Reis, N., Glaser, F., & Glickman, M. H. (2022). Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15). Seminars in Cell & Developmental Biology, 132, 16-26. https://doi.org/10.1016/j.semcdb.2022.06.005

[59] Chen, N., Jin, J., Zhang, B., Meng, Q., Lu, Y., Liang, B., ..., & Zheng, L. (2024). Viral strategies to antagonize the host antiviral innate immunity: An indispensable research direction for emerging virus-host interactions. Emerging Microbes & Infections, 13(1), 2341144. https://doi.org/10.1080/22221751.2024.2341144

[60] Huang, B., Luo, J., Liu, L. Y., Deng, W. S., Wang, K., Lu, H. S., & Kong, J. L. (2022). Deciphering the mechanism of YuPingFeng granules in treating pneumonia: A network pharmacology and molecular docking study. Evidence-Based Complementary and Alternative Medicine, 2022(1), 4161235. https://doi.org/10.1155/2022/4161235

[61] Liu, Z., Sun, Q., Liu, X., Song, Z., Song, F., Lu, C., ..., & Li, Y. (2022). Network pharmacology analysis and experimental verification reveal the mechanism of the traditional Chinese medicine YU-Pingfeng San alleviating allergic rhinitis inflammatory responses. Frontiers in Plant Science, 13, 934130. https://doi.org/10.3389/fpls.2022.934130

[62] Li, M., Yue, X., Gao, Y., Zhang, B., Yuan, C., & Wu, T. (2020). Method for rapidly discovering active components in Yupingfeng granules by UPLC-ESI-Q-TOF-MS. Journal of Mass Spectrometry, 55(10), e4627. https://doi.org/10.1002/jms.4627

[63] Ghabeshi, S., Mousavizadeh, L., & Ghasemi, S. (2023). Enhancing the antiviral potential and anti-inflammatory properties of astragalus membranaceus: A comprehensive review. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents), 22(4), 211-219. https://doi.org/10.2174/0118715230280333231207114927

[64] Dong, M., Li, J., Yang, D., Li, M., & Wei, J. (2023). Biosynthesis and pharmacological activities of flavonoids, Triterpene Saponins and polysaccharides derived from Astragalus membranaceus. Molecules, 28(13), 5018. https://doi.org/10.3390/molecules28135018

[65] Sheng, Z., Jiang, Y., Liu, J., & Yang, B. (2021). UHPLC-MS/MS analysis on flavonoids composition in Astragalus membranaceus and their antioxidant activity. Antioxidants, 10(11), 1852. https://doi.org/10.3390/antiox10111852

[66] Zhang, J., Wu, C., Gao, L., Du, G., & Qin, X. (2020). Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects. Advances in Pharmacology, 87, 89-112. https://doi.org/10.1016/bs.apha.2019.08.002

[67] Ruqiao, L., Yueli, C., Xuelan, Z., Huifen, L., Xin, Z., Danjie, Z., ..., & Yanxue, Z. (2020). Rhizoma Atractylodis macrocephalae: A review of photochemistry, pharmacokinetics and pharmacology. Die Pharmazie - An International Journal of Pharmaceutical Sciences, 75(2-3), 42-55.

[68] Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., ..., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, 10(5), 766-788. https://doi.org/10.1016/j.apsb.2020.02.008

[69] Yu, Y., Zhang, G., Han, T., Liu, H., & Huang, H. (2022). Potential material basis of Yupingfeng powder for the prevention and treatment of 2019 novel coronavirus pneumonia: A study involving molecular docking and molecular dynamic simulation Technology. BioMed Research International, 2022(1), 7892397. https://doi.org/10.1155/2022/7892397

[70] Wang, L., Du, Z., Guan, Y., Wang, B., Pei, Y., Zhang, L., & Fang, M. (2022). Identifying absorbable bioactive constituents of Yupingfeng powder acting on COVID-19 through integration of UPLC-Q/TOF-MS and network pharmacology analysis. Chinese Herbal Medicines, 14(2), 283-293. https://doi.org/10.1016/j.chmed.2022.02.001

[71] Pang, X., Ren, L., Wu, S., Ma, W., Yang, J., Di, L., ..., & COVID-19 Laboratory Testing Group. (2020). COVID-19 Laboratory Testing Group. (2020). Cold-chain food contamination as the possible origin of COVID-19 resurgence in Beijing. National Science Review, 7(12), 1861-1864. https://doi.org/10.1093/nsr/nwaa264

[72] Dhochak, N., Singhal, T., Kabra, S. K., & Lodha, R. (2020). Pathophysiology of COVID-19: Why children fare better than adults? The Indian Journal of Pediatrics, 87, 537-546. https://doi.org/10.1007/s12098-020-03322-y

[73] Wise, J. (2020). Covid-19: New coronavirus variant is identified in UK. BMJ, 371, m4857. https://doi.org/10.1136/bmj.m4857

[74] Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y. Q., ..., & Zhou, Y. (2020). Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science, 369(6511), 1603-1607. https://doi.org/10.1126/science.abc4730

[75] Ahamad, S., Kanipakam, H., & Gupta, D. (2022). Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 40(1), 263-275. https://doi.org/10.1080/07391102.2020.1811774

[76] Xian, Y., Zhang, J., Bian, Z., Zhou, H., Zhang, Z., Lin, Z., & Xu, H. (2020). Bioactive natural compounds against human coronaviruses: A review and perspective. Acta Pharmaceutica Sinica B, 10(7), 1163-1174. https://doi.org/10.1016/j.apsb.2020.06.002

[77] Tong, T., Wu, Y. Q., Ni, W. J., Shen, A. Z., & Liu, S. (2020). The potential insights of Traditional Chinese medicine on treatment of COVID-19. Chinese Medicine, 15, 51. https://doi.org/10.1186/s13020-020-00326-w